ISRCTN70913605
Completed
Not Applicable
A study of patients with multi-vessel disease presenting with acute myocardial infarction undergoing primary percutaneous coronary intervention (PPCI) including a prospective registry of all PPCI patients and a pilot study in a subset of patients with multi-vessel coronary disease randomised to a strategy of early multi-vessel revascularisation or infarct related artery revascularisation only
niversity Hospitals of Leicester NHS Trust (UK)0 sites1,250 target enrollmentFebruary 24, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ST elevation myocardial infarction (STEMI)
- Sponsor
- niversity Hospitals of Leicester NHS Trust (UK)
- Enrollment
- 1250
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Suspected or proven acute myocardial infarction
- •2\. Significant ST elevation on electrocardiogram (ECG)
- •3\. Less than 12 hours of symptom onset
- •4\. Scheduled for primary percutaneous coronary intervention (PCI) for clinical reasons
- •5\. Provision of verbal assent followed by written informed consent
- •1\. Suspected or proven acute myocardial infarction
- •2\. Significant ST elevation on ECG
- •3\. Less than 12 hours of symptom onset
- •4\. Scheduled for Primary PCI for clinical reasons
- •5\. Provision of verbal assent followed by written informed consent
Exclusion Criteria
- •There are no formal exclusion criteria for the CVLPRIT registry for patients that meet the inclusion criteria.
- •1\. Any contraindication to PPCI or multi\-vessel PPCI
- •2\. Less than 18 years age
- •3\. Clear indication for or contraindication to multivessel PPCI, according to operator judgement and the reasons will be documented
- •4\. Severe kidney impairment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Multicenter research on Vasal diseaseVasal diseaseJPRN-UMIN000040834Tohoku University Hospital25,000
Completed
Not Applicable
Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)JPRN-UMIN000000492agoya University160
Completed
Not Applicable
Does the use of intravascular ultrasound improve outcomes of endovascular interventional procedures for peripheral vascular disease of the superficial femoral artery or popliteal artery?Peripheral Arterial DiseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12614000006640Department of Vascular Surgery, Flinders Medical Centre150
Unknown
Phase 4
Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-DisappearsCoronary Artery DiseaseNCT02004730I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1,000
Completed
Not Applicable
Comparison of Vascular Risk in Patients Treated for Obstructive Sleep Apnea/Hypopnea SyndromeObstructive Sleep Apnea/Hypopnea SyndromeNCT05491967Centre Hospitalier de Valence172